Moran Wealth Management, LLC Halozyme Therapeutics, Inc. Transaction History
Moran Wealth Management, LLC
- $3.16 Billion
- Q3 2025
A detailed history of Moran Wealth Management, LLC transactions in Halozyme Therapeutics, Inc. stock. As of the latest transaction made, Moran Wealth Management, LLC holds 35,445 shares of HALO stock, worth $2.29 Million. This represents 0.08% of its overall portfolio holdings.
Number of Shares
35,445
Previous 9,793
261.94%
Holding current value
$2.29 Million
Previous $509,000
410.61%
% of portfolio
0.08%
Previous 0.02%
Shares
2 transactions
Others Institutions Holding HALO
# of Institutions
629Shares Held
127MCall Options Held
408KPut Options Held
384K-
Black Rock Inc. New York, NY17.6MShares$1.14 Billion0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA12.2MShares$791 Million0.01% of portfolio
-
State Street Corp Boston, MA5.94MShares$384 Million0.01% of portfolio
-
Invesco Ltd. Atlanta, GA3.47MShares$224 Million0.03% of portfolio
-
Snyder Capital Management L P San Francisco, CA3.4MShares$220 Million3.92% of portfolio
About HALOZYME THERAPEUTICS, INC.
- Ticker HALO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 139,288,992
- Market Cap $9B
- Description
- Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable...